Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5,10-methylene-5,6,7,8-tetrahydrofolate
2. 5,10-methylenetetrahydrofolate
3. 5,10-methylenetetrahydrofolate Monohydrochloride, (l-glu)-isomer
4. 5,10-methylenetetrahydrofolate, (d-glu)-isomer
5. 5,10-methylenetetrahydrofolate, (l-glu)-(s)-isomer
6. 5,10-methylenetetrahydrofolic Acid
7. Ch2h4fol
8. Ch2h4folate
9. N5,n10-methylene-5,6,7,8-tetrahydrofolic Acid
10. Tetrahydromethylenefolate
1. Arfolitixorin
2. 31690-11-6
3. Modufolin
4. 6r-mthf
5. Methylenetetrahydrofolic Acid, L-(+)-
6. Arfolitixorin [usan]
7. (6r)-5,10-methylenetetrahydrofolic Acid
8. Chebi:1989
9. Z8r4a37v9q
10. Iso-901
11. L-(+)-methylenetetrahydrofolic Acid
12. 5,10-methylene-thf
13. 5,10-methylene-(6r)-tetrahydrofolic Acid
14. (2s)-2-[[4-[(6ar)-3-amino-1-oxo-4,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic Acid
15. 3432-99-3
16. 5,10-methylenetetrahydrofolate
17. N-({4-[(6ar)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9h)-yl]phenyl}carbonyl)-l-glutamic Acid
18. N-{4-[(6ar)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9h)-yl]benzoyl}-l-glutamic Acid
19. Unii-z8r4a37v9q
20. Arfolitixorin [inn]
21. Arfolitixorin (usan/inn)
22. Schembl186747
23. Arfolitixorin [who-dd]
24. Chembl1234270
25. Dtxsid60185584
26. Bcp09003
27. Zinc4228243
28. (6r)-5,10-mthf
29. Who 10689
30. Db12676
31. 5,10-methylene,5,6,7,8-tetrahydrofolate
32. D11447
33. D-n5,n10-methylene-l-tetrahydrofolic Acid
34. Q26995704
35. (6r,s)-5,10-methylene-5,6,7,8-tetrahydrofolic Acid
36. [6r]-5,10-methylenetetrahydrofolate ([6r]-5,10- Mthf)
37. (6r)-5,10-methylene-5,6,7,8-tetrahydrofolic Acid
38. (2s)-2-[[4-[(6ar)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic Acid
39. (s)-2-(4-((r)-3-amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1h,4h,9h)-yl)benzamido)pentanedioic Acid
40. (s)-2-(4-((r)-3-amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1h,4h,9h)-yl)benzamido)pentanedioicacid
41. L-glutamic Acid, N-(4-((6ar)-3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo(1,5-f)pteridin-8(9h)-yl)benzoyl)-
42. N-({4-[(6ar)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9h)-yl]phenyl}carbonyl)-l-glutamic Acid
43. N-(4-((6ar)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo(1,5-f)pteridin-8(9h)- Yl)benzoyl)-l-glutamic Acid
| Molecular Weight | 457.4 g/mol |
|---|---|
| Molecular Formula | C20H23N7O6 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 457.17098148 g/mol |
| Monoisotopic Mass | 457.17098148 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 911 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of colorectal cancer
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Arfolitixorin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arfolitixorin, including repackagers and relabelers. The FDA regulates Arfolitixorin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arfolitixorin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arfolitixorin supplier is an individual or a company that provides Arfolitixorin active pharmaceutical ingredient (API) or Arfolitixorin finished formulations upon request. The Arfolitixorin suppliers may include Arfolitixorin API manufacturers, exporters, distributors and traders.
Arfolitixorin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Arfolitixorin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arfolitixorin GMP manufacturer or Arfolitixorin GMP API supplier for your needs.
A Arfolitixorin CoA (Certificate of Analysis) is a formal document that attests to Arfolitixorin's compliance with Arfolitixorin specifications and serves as a tool for batch-level quality control.
Arfolitixorin CoA mostly includes findings from lab analyses of a specific batch. For each Arfolitixorin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Arfolitixorin may be tested according to a variety of international standards, such as European Pharmacopoeia (Arfolitixorin EP), Arfolitixorin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arfolitixorin USP).
LOOKING FOR A SUPPLIER?
